Talk:Merozoite surface protein

	This article is within the scope of WikiProject Molecular Biology, a collaborative effort to improve the coverage of Molecular Biology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.Molecular BiologyWikipedia:WikiProject Molecular BiologyTemplate:WikiProject Molecular BiologyMolecular Biology articles
???	This article has not yet received a rating on the importance scale.
	This article is supported by the Molecular and Cell Biology task force (assessed as Low-importance).

Wiki Education Foundation-supported course assignment

This article is or was the subject of a Wiki Education Foundation-supported course assignment. Further details are available on the course page. Student editor(s): Cedombroski.

Above undated message substituted from Template:Dashboard.wikiedu.org assignment by PrimeBOT (talk) 03:55, 17 January 2022 (UTC)[reply]

Adding New Information

I found these sources and think that they provide comprehensive information that would improve this article:

N-Terminal Plasmodium vivax Merozoite Surface Protein-1, a Potential Subunit for Malaria Vivax Vaccine^[1]
Merozoite surface proteins in red blood cell invasion, immunity and vaccines against malaria.^[2]
Suramin & suramin analogues inhibit merozoite surface protein-1 secondary processing and erythrocyte invasion by the malaria parasite Plasmodium falciparum.^[3]
Designing malaria vaccines to circumvent antigen variability.^[4]
The carboxy-terminus of merozoite surface protein 1: structure, specific antibodies and immunity to malaria.^[5]
Signaling Strategies of Malaria Parasite for Its Survival, Proliferation, and Infection during Erythrocytic Stage.^[6]

Any feedback would be welcome Cedombroski (talk) 23:13, 25 October 2018 (UTC)[reply]

References

^ Versiani, Fernanda G.; Almeida, Maria E.; Mariuba, Luis A.; Orlandi, Patricia P.; Nogueira, Paulo A. (2013). "N-terminal Plasmodium vivax merozoite surface protein-1, a potential subunit for malaria vivax vaccine". Clinical & Developmental Immunology. 2013: 965841. doi:10.1155/2013/965841. ISSN 1740-2530. PMC 3804292. PMID 24187566.{{cite journal}}: CS1 maint: PMC format (link) CS1 maint: unflagged free DOI (link)
^ Beeson, James G.; Drew, Damien R.; Boyle, Michelle J.; Feng, Gaoqian; Fowkes, Freya J.I.; Richards, Jack S. (2016-01-31). "Merozoite surface proteins in red blood cell invasion, immunity and vaccines against malaria". FEMS Microbiology Reviews. 40 (3): 343–372. doi:10.1093/femsre/fuw001. ISSN 1574-6976.
^ Fleck, Suzanne L.; Birdsall, Berry; Babon, Jeffrey; Dluzewski, Anton R.; Martin, Stephen R.; Morgan, William D.; Angov, Evelina; Kettleborough, Catherine A.; Feeney, James (2003-11-28). "Suramin and suramin analogues inhibit merozoite surface protein-1 secondary processing and erythrocyte invasion by the malaria parasite Plasmodium falciparum". The Journal of Biological Chemistry. 278 (48): 47670–47677. doi:10.1074/jbc.M306603200. ISSN 0021-9258. PMID 13679371.{{cite journal}}: CS1 maint: unflagged free DOI (link)
^ Ouattara, Amed; Barry, Alyssa E.; Dutta, Sheetij; Remarque, Edmond J.; Beeson, James G.; Plowe, Christopher V. (2015-12-22). "Designing malaria vaccines to circumvent antigen variability". Vaccine. 33 (52): 7506–7512. doi:10.1016/j.vaccine.2015.09.110. ISSN 1873-2518. PMC 4731100. PMID 26475447.{{cite journal}}: CS1 maint: PMC format (link)
^ Holder, A. A. (2009-07-23). "The carboxy-terminus of merozoite surface protein 1: structure, specific antibodies and immunity to malaria". Parasitology. 136 (12): 1445–1456. doi:10.1017/S0031182009990515. ISSN 1469-8161. PMID 19627632.
^ Soni, Rani; Sharma, Drista; Rai, Praveen; Sharma, Bhaskar; Bhatt, Tarun K. (2017). "Signaling Strategies of Malaria Parasite for Its Survival, Proliferation, and Infection during Erythrocytic Stage". Frontiers in Immunology. 8: 349. doi:10.3389/fimmu.2017.00349. ISSN 1664-3224. PMC 5368685. PMID 28400771.{{cite journal}}: CS1 maint: PMC format (link) CS1 maint: unflagged free DOI (link)

[:0-1] Versiani, Fernanda G.; Almeida, Maria E.; Mariuba, Luis A.; Orlandi, Patricia P.; Nogueira, Paulo A. (2013). "N-terminal Plasmodium vivax merozoite surface protein-1, a potential subunit for malaria vivax vaccine". Clinical & Developmental Immunology. 2013: 965841. doi:10.1155/2013/965841. ISSN 1740-2530. PMC 3804292. PMID 24187566.{{cite journal}}: CS1 maint: PMC format (link) CS1 maint: unflagged free DOI (link)

[:1-2] Beeson, James G.; Drew, Damien R.; Boyle, Michelle J.; Feng, Gaoqian; Fowkes, Freya J.I.; Richards, Jack S. (2016-01-31). "Merozoite surface proteins in red blood cell invasion, immunity and vaccines against malaria". FEMS Microbiology Reviews. 40 (3): 343–372. doi:10.1093/femsre/fuw001. ISSN 1574-6976.

[:2-3] Fleck, Suzanne L.; Birdsall, Berry; Babon, Jeffrey; Dluzewski, Anton R.; Martin, Stephen R.; Morgan, William D.; Angov, Evelina; Kettleborough, Catherine A.; Feeney, James (2003-11-28). "Suramin and suramin analogues inhibit merozoite surface protein-1 secondary processing and erythrocyte invasion by the malaria parasite Plasmodium falciparum". The Journal of Biological Chemistry. 278 (48): 47670–47677. doi:10.1074/jbc.M306603200. ISSN 0021-9258. PMID 13679371.{{cite journal}}: CS1 maint: unflagged free DOI (link)

[:3-4] Ouattara, Amed; Barry, Alyssa E.; Dutta, Sheetij; Remarque, Edmond J.; Beeson, James G.; Plowe, Christopher V. (2015-12-22). "Designing malaria vaccines to circumvent antigen variability". Vaccine. 33 (52): 7506–7512. doi:10.1016/j.vaccine.2015.09.110. ISSN 1873-2518. PMC 4731100. PMID 26475447.{{cite journal}}: CS1 maint: PMC format (link)

[:4-5] Holder, A. A. (2009-07-23). "The carboxy-terminus of merozoite surface protein 1: structure, specific antibodies and immunity to malaria". Parasitology. 136 (12): 1445–1456. doi:10.1017/S0031182009990515. ISSN 1469-8161. PMID 19627632.

[:5-6] Soni, Rani; Sharma, Drista; Rai, Praveen; Sharma, Bhaskar; Bhatt, Tarun K. (2017). "Signaling Strategies of Malaria Parasite for Its Survival, Proliferation, and Infection during Erythrocytic Stage". Frontiers in Immunology. 8: 349. doi:10.3389/fimmu.2017.00349. ISSN 1664-3224. PMC 5368685. PMID 28400771.{{cite journal}}: CS1 maint: PMC format (link) CS1 maint: unflagged free DOI (link)

[1]

[2]

[3]

[4]

[5]

[6]